Back to search
Progressive Multiple Sclerosis (PMS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Progressive Multiple Sclerosis (PMS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Progressive Multiple Sclerosis (PMS) trials you may qualify forThis trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolera…
The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).
The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple Sclero…
This is an open-label, multi-center, non-confirmatory study to assess the safety, disease progression, and cellular kinetics following YTB323 administration to…
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sclerosis (PMS).
This study investigates whether a structured exercise program using coordinated movements of both arms can improve brain and motor function in people with Progr…